{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:30:04Z","timestamp":1791462604389,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.nmd.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T16:30:27Z","timestamp":1478190627000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Quantification of muscle pathology in infantile Pompe disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Anne","family":"Sch\u00e4nzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"M\u00fchlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kulessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"von Pein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Viergutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen","family":"Mengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Acker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2016.10.010_bib0010","series-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. The metabolic and molecular bases of inherited disease","first-page":"3389","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.nmd.2016.10.010_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"Van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2016.10.010_bib0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human \u03b1-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.nmd.2016.10.010_bib0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human \u03b1-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2016.10.010_bib0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2016.10.010_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human \u03b1-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2016.10.010_bib0040","first-page":"65","article-title":"Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany","volume":"20","author":"Hahn","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.nmd.2016.10.010_bib0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10545-010-9206-3","article-title":"Treatment of infantile Pompe disease with alglucosidase alpha: the UK experience","volume":"33","author":"Chakrapani","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2016.10.010_bib0050","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10545-014-9707-6","article-title":"Enzyme therapy and immune response in relation to CRIM status: the Dutch experience in classic infantile Pompe disease","volume":"38","author":"Van Gelder","year":"2015","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.nmd.2016.10.010_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ajmg.c.31319","article-title":"Predicting cross-reactive immunological material (CRIM) status in Pompe disease using GAA mutations: lessons learned from 10 years of clinical laboratory testing experience","volume":"160C","author":"Bali","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.nmd.2016.10.010_bib0060","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1542\/peds.2008-3667","article-title":"Pompe disease in infants: improving the prognosis by newborn screening and early treatment","volume":"124","author":"Chien","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2016.10.010_bib0065","first-page":"102","article-title":"Lysosomal storage disease: revealing lysosomal function and physiology","volume":"25","author":"Parkinson-Lawrence","year":"2010","journal-title":"Physiology (Bethesda)"},{"issue":"1","key":"10.1016\/j.nmd.2016.10.010_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160C","author":"Young","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.nmd.2016.10.010_bib0075","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.nmd.2016.10.010_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High-resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"Lynch","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.nmd.2016.10.010_bib0085","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2016.10.010_bib0090","first-page":"Jun20","article-title":"Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy","volume":"90","author":"Prater","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2016.10.010_bib0095","series-title":"Muscle biopsy: a practical approach","author":"Dubowitz","year":"2013"},{"key":"10.1016\/j.nmd.2016.10.010_bib0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carpath.2008.10.015","article-title":"A review of state-of-the-art stereology for better quantitative 3D morphology in cardiac research","volume":"19","author":"M\u00fchlfeld","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.nmd.2016.10.010_bib0105","first-page":"177","article-title":"Pompe disease: from pathophysiology to therapy and back again","volume":"23","author":"Lim","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nmd.2016.10.010_bib0110","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/nan.12214","article-title":"Impaired autophagy affects acid \u03b1-glucosidase processing and enzyme replacementtherapy efficacy in late-onset glycogen storage disease type II","volume":"41","author":"Nascimbeni","year":"2015","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2016.10.010_bib0115","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.4161\/auto.21691","article-title":"Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients","volume":"8","author":"Nascimbeni","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.nmd.2016.10.010_bib0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2990.2007.00839.x","article-title":"Adult-onset glycogen storage disease type 2: clinico-pathological phenotype revisited","volume":"33","author":"Schoser","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.nmd.2016.10.010_bib0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nmd.2008.04.010","article-title":"Lyososmal myopathies: an excesive build-ip in autophagosomes is too much to handle","volume":"18","author":"Malicdan","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2016.10.010_bib0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1750-3639.2011.00543.x","article-title":"Autophagy in lysosomal myopathies","volume":"22","author":"Malicdan","year":"2012","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nmd.2016.10.010_bib0135","doi-asserted-by":"crossref","DOI":"10.1186\/2051-5960-2-2","article-title":"The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients","volume":"2","author":"Feeney","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.nmd.2016.10.010_bib0140","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2013murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nmd.2016.10.010_bib0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ymgme.2011.07.014","article-title":"The use of dried blood spot samples in the diagnosis of lysosomal storage disorders-current status and perspectives","volume":"104","author":"Reuser","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2016.10.010_bib0150","first-page":"114","article-title":"New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond","volume":"12","author":"Kishnani","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"10.1016\/j.nmd.2016.10.010_bib0155","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.nmd.2014.09.016","article-title":"Muscle ultrasound in classic infantile and adult Pompe disease: a useful screening tool in adults but not in infants","volume":"25","author":"Vill","year":"2015","journal-title":"Neuromuscul Disord"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616307891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616307891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:04:51Z","timestamp":1760774691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616307891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0960896616307891"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2016.10.010","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of muscle pathology in infantile Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}